Nanexa AB
556833-0285ActiveNanexa redefines injectables using proprietary nanoengineering drug delivery technology.
Översikt
- 10–19
- Anställda
- 5–10milj SEK
- Omsättning
- 2010
- Grundat
Nyckelbeslutsfattare
Anders Johansson
Head of Intellectual Property
David Westberg
Chief Executive Officer
Bridget Lacey
Chief Business Officer
Göran Ando
Chairman of the Board
+15 fler kontakter i Funnelfeedr
Beskrivning
Nanexa is a pharmaceutical development company specializing in advanced drug delivery systems. Their core innovation is the proprietary PharmaShell® technology, which utilizes Atomic Layer Deposition (ALD) precision. This technology is designed to transform drug administration by enabling long-actin...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556833028501
Beslutsfattare
19 kontakter i FunnelfeedrAnders Johansson
Head of Intellectual Property
David Westberg
Chief Executive Officer
Bridget Lacey
Chief Business Officer
Göran Ando
Chairman of the Board
Marie Gårdmark
Director Regulatory Affairs
Cecilia Danckwardt-Lillieström
Chief Financial Officer
Bengt Gustavsson
Board Member
Polla Rouf
Head of R&D ALD
Sven Undeland
Director Strategic Market Analysis
Jonas Fransson
Head of Pharmaceutical Development
Mikael Asp
Head of Quality Assurance, Special Advisor
Jakob Dynnes Hansen
Board Member
Richard Davis
Board Member
Kristine Bäck
Director Project Management
Joel Hellrup
Head of Pharmaceutical R&D
Mårten Rooth
Chief Technology Officer, Co-founder
Hanna Tilus
Board Member
Birgit Stattin Norinder
Board Member
Björn Svanström
current CFO (leaving)
Liknande företag
20 liknande företag i Funnelfeedr
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
Iconovo AB
10–19 anställdaLeading partner developing patented dry powder inhaler drug delivery systems.
Double Bond Pharmaceutical AB
5–9 anställdaDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
AcroPharma AB (publ)
0 anställdaDeveloping innovative preventive therapeutics for major human diseases.
PILA PHARMA AB
1–4 anställdaClinical stage biotech developing an oral obesity and diabetes treatment.
Utforska mer
Frågor om Nanexa AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo